US BANCORP \DE\ - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 71 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.2%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2022$1,000
-83.3%
2,000
-80.0%
0.00%
Q2 2022$6,000
-45.5%
10,0000.0%0.00%
Q1 2022$11,000
-26.7%
10,000
+990.5%
0.00%
Q3 2018$15,0009170.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Mayo Clinic 1,571,981$9,431,886,00010.86%
Invus Financial Advisors, LLC 1,094,998$6,570,0001.51%
Founders Fund V Management, LLC 491,751$2,951,0000.16%
Arbor Wealth Management, LLC 25,888$155,0000.05%
PDT Partners, LLC 70,233$421,0000.03%
JACOBS LEVY EQUITY MANAGEMENT, INC 575,443$3,453,0000.03%
NATIONS FINANCIAL GROUP INC, /IA/ /ADV 18,644$112,0000.02%
Fort Point Capital Partners LLC 10,000$60,0000.01%
Baillie Gifford 3,803,014$22,818,0000.01%
Summit Trail Advisors, LLC 13,458$81,0000.01%
View complete list of UNITY BIOTECHNOLOGY INC shareholders